Smith+Nephew's revenue rebound: A 3-year comparison

Carly Behm -   Print  |

Although Smith+Nephew's overall first quarter revenue has grown since the same period in 2019, orthopedic revenue is still catching up to pre-pandemic figures.

Here's a year-over-year comparison of Smith+Nephew's first-quarter performance in the last three years:

Q1 2021
Revenue: $1.3 billion
Total orthopedic sales: $540 million
Knee sales: $212 million
Hip sales: $154 million
Trauma sales: $149 million

Q1 2020
Revenue: $1.1 billion
Total orthopedic sales: $497 million
Knee sales: $230 million
Hip sales: $137 million
Trauma sales: $109 million

Q1 2019
Net sales: $1.2 billion
Total orthopedic sales: $546 million
Knee sales: $261 million
Hip sales: $152 million
Trauma sales: $119 million

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers